Coronary Artery Disease, Valve Heart Disease
Conditions
Keywords
prognosis, translational research
Brief summary
To explore predictors of major cardio-vascular events after cardiac surgery and trans-catheter valve implantation with a specific interest in studying mechanisms linking pre-operative leukocyte, fat and myocardial phenotypes with post-intervention outcomes.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* patients scheduled for cardiac surgery (coronary artery bypass graft surgery and/or valvular surgery) or transcatheter valve implantation
Exclusion criteria
* pregnant woman * urgent surgery or intervention * not able to consent to the protocol
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| major cardio-vascular events after cardiac intervention (surgery or transcatheter valve implantation) | from the day of intervention to 10 years | cardiovascular death, hospitalisation for heart failure, stroke, myocardial infarction, re-intervention |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| peri-operative myocardial injury | 3 days following intervention | Area Under the Curve of blood troponin release during the 3 days following cardiac intervention |
| post-operative myocardial infarction (type 5 myocardial infarction) | 10 days following intervention | myocardial infarction during the peri-operative time |
| post-operative atrial fibrillation | 10 days following intervention | atrial fibrillation onset during post-op hospitalisation |
| major cardio-vascular events after cardiac intervention (surgery or transcatheter valve implantation) | from the day of intervention to 1 year | cardiovascular death, hospitalisation for heart failure, stroke, myocardial infarction, re-intervention |
Countries
France
Contacts
University Hospital, Lille